JPH0368180B2 - - Google Patents
Info
- Publication number
- JPH0368180B2 JPH0368180B2 JP1170686A JP1170686A JPH0368180B2 JP H0368180 B2 JPH0368180 B2 JP H0368180B2 JP 1170686 A JP1170686 A JP 1170686A JP 1170686 A JP1170686 A JP 1170686A JP H0368180 B2 JPH0368180 B2 JP H0368180B2
- Authority
- JP
- Japan
- Prior art keywords
- termite
- formwork
- board
- concrete foundation
- concrete
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000256602 Isoptera Species 0.000 claims description 20
- 238000009415 formwork Methods 0.000 claims description 16
- 230000002265 prevention Effects 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 9
- 238000005452 bending Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000009434 installation Methods 0.000 claims description 3
- 238000010276 construction Methods 0.000 description 7
- 241001070941 Castanea Species 0.000 description 4
- 235000014036 Castanea Nutrition 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 239000004575 stone Substances 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
Landscapes
- Building Environments (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1170686A JPS62170639A (ja) | 1986-01-22 | 1986-01-22 | 防蟻板の取付け工法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1170686A JPS62170639A (ja) | 1986-01-22 | 1986-01-22 | 防蟻板の取付け工法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62170639A JPS62170639A (ja) | 1987-07-27 |
| JPH0368180B2 true JPH0368180B2 (ko) | 1991-10-25 |
Family
ID=11785487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1170686A Granted JPS62170639A (ja) | 1986-01-22 | 1986-01-22 | 防蟻板の取付け工法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62170639A (ko) |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004050683A2 (en) | 2002-12-02 | 2004-06-17 | Abgenix, Inc. | Antibodies directed to tumor necrosis factor and uses thereof |
| WO2005016111A2 (en) | 2003-08-08 | 2005-02-24 | Abgenix, Inc. | Antibodies directed to parathyroid hormone (pth) and uses thereof |
| WO2005092926A2 (en) | 2004-03-19 | 2005-10-06 | Amgen Inc. | Reducing the risk of human and anti-human antibodies through v gene manipulation |
| WO2006055638A2 (en) | 2004-11-17 | 2006-05-26 | Abgenix, Inc. | Fully human monoclonal antibodies to il-13 |
| WO2007059082A1 (en) | 2005-11-10 | 2007-05-24 | Curagen Corporation | Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen |
| WO2009040134A1 (en) | 2007-09-26 | 2009-04-02 | U3 Pharma Gmbh | Heparin-binding epidermal growth factor-like growth factor antigen binding proteins |
| WO2010072740A2 (en) | 2008-12-23 | 2010-07-01 | Astrazeneca Ab | TARGETED BINDING AGENTS DIRECTED TO α5β1 AND USES THEREOF |
| WO2011060206A2 (en) | 2009-11-13 | 2011-05-19 | U3 Pharma Gmbh | Material and methods for treating or preventing her-3 associated diseases |
| EP2357202A1 (en) | 2006-04-10 | 2011-08-17 | AstraZeneca AB | Targeted binding agents directed to Upar and uses thereof |
| EP2361933A2 (en) | 2005-01-26 | 2011-08-31 | Amgen Fremont Inc. | Antibodies against interleukin-1 beta |
| EP2404616A2 (en) | 2005-12-13 | 2012-01-11 | AstraZeneca AB | Binding proteins specific for insulin-like growth factors and uses thereof |
| WO2012018404A2 (en) | 2010-08-06 | 2012-02-09 | U3 Pharma Gmbh | Use of her3 binding agents in prostate treatment |
| EP2420513A1 (en) | 2006-08-03 | 2012-02-22 | MedImmune Limited | Targeted binding agents directed to PDGFR-alpha and uses thereof |
| WO2012154999A1 (en) | 2011-05-10 | 2012-11-15 | Amgen Inc. | Methods of treating or preventing cholesterol related disorders |
| WO2013075048A1 (en) | 2011-11-16 | 2013-05-23 | Amgen Inc. | Methods of treating epidermal growth factor deletion mutant viii related disorders |
| US8597615B2 (en) | 2004-03-19 | 2013-12-03 | Amgen Fremont Inc. | Methods of monitoring a human anti-human antibody response and inhibitors thereof |
| US9062113B2 (en) | 2003-06-27 | 2015-06-23 | Amgen Fremont Inc. | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| EP2927244A1 (en) | 2008-09-19 | 2015-10-07 | MedImmune, LLC | Antibodies directed to DLL4 and uses thereof |
| WO2016016859A1 (en) | 2014-07-31 | 2016-02-04 | Amgen Research (Munich) Gmbh | Optimized cross-species specific bispecific single chain antibody constructs |
| WO2016166360A1 (en) | 2015-04-17 | 2016-10-20 | Bayer Pharma Aktiengesellschaft | Bispecific antibody constructs for cdh3 and cd3 |
| EP3196213A2 (en) | 2005-12-30 | 2017-07-26 | Daiichi Sankyo Europe GmbH | Antibodies directed to her-3 and uses thereof |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002371643A (ja) * | 2001-06-14 | 2002-12-26 | Termimesh Japan Kk | 建物の防蟻構造及び防蟻工法、その建物、並びにコンクリート型枠 |
| JP2010043464A (ja) * | 2008-08-12 | 2010-02-25 | Sanyo Homes Kk | 防蟻部材、建物基礎の製造方法、及び防蟻方法 |
| JP5468849B2 (ja) * | 2009-06-19 | 2014-04-09 | 和治 藤井 | 防蟻装置、及び防蟻工法 |
-
1986
- 1986-01-22 JP JP1170686A patent/JPS62170639A/ja active Granted
Cited By (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004050683A2 (en) | 2002-12-02 | 2004-06-17 | Abgenix, Inc. | Antibodies directed to tumor necrosis factor and uses thereof |
| US9096672B2 (en) | 2003-06-27 | 2015-08-04 | Amgen Fremont Inc. | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| US9085624B2 (en) | 2003-06-27 | 2015-07-21 | Amgen Fremont Inc. | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| US9073998B2 (en) | 2003-06-27 | 2015-07-07 | Amgen Fremont Inc. | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| US9062113B2 (en) | 2003-06-27 | 2015-06-23 | Amgen Fremont Inc. | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| WO2005016111A2 (en) | 2003-08-08 | 2005-02-24 | Abgenix, Inc. | Antibodies directed to parathyroid hormone (pth) and uses thereof |
| WO2005092926A2 (en) | 2004-03-19 | 2005-10-06 | Amgen Inc. | Reducing the risk of human and anti-human antibodies through v gene manipulation |
| US8597615B2 (en) | 2004-03-19 | 2013-12-03 | Amgen Fremont Inc. | Methods of monitoring a human anti-human antibody response and inhibitors thereof |
| WO2006055638A2 (en) | 2004-11-17 | 2006-05-26 | Abgenix, Inc. | Fully human monoclonal antibodies to il-13 |
| EP2361933A2 (en) | 2005-01-26 | 2011-08-31 | Amgen Fremont Inc. | Antibodies against interleukin-1 beta |
| WO2007059082A1 (en) | 2005-11-10 | 2007-05-24 | Curagen Corporation | Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen |
| EP2404616A2 (en) | 2005-12-13 | 2012-01-11 | AstraZeneca AB | Binding proteins specific for insulin-like growth factors and uses thereof |
| EP3196213A2 (en) | 2005-12-30 | 2017-07-26 | Daiichi Sankyo Europe GmbH | Antibodies directed to her-3 and uses thereof |
| US9988462B2 (en) | 2005-12-30 | 2018-06-05 | Daiichi Sankyo Europe Gmbh | Material and methods for treating or preventing HER-3 associated diseases |
| EP2357202A1 (en) | 2006-04-10 | 2011-08-17 | AstraZeneca AB | Targeted binding agents directed to Upar and uses thereof |
| EP2420514A1 (en) | 2006-08-03 | 2012-02-22 | MedImmune Limited | Targeted binding agents directed to PDGFR-alpha and uses thereof |
| EP2420513A1 (en) | 2006-08-03 | 2012-02-22 | MedImmune Limited | Targeted binding agents directed to PDGFR-alpha and uses thereof |
| EP2497783A2 (en) | 2007-09-26 | 2012-09-12 | U3 Pharma GmbH | Heparin-binding epidermal growth factor-like growth factor antigen binding proteins |
| WO2009040134A1 (en) | 2007-09-26 | 2009-04-02 | U3 Pharma Gmbh | Heparin-binding epidermal growth factor-like growth factor antigen binding proteins |
| EP2927244A1 (en) | 2008-09-19 | 2015-10-07 | MedImmune, LLC | Antibodies directed to DLL4 and uses thereof |
| WO2010072740A2 (en) | 2008-12-23 | 2010-07-01 | Astrazeneca Ab | TARGETED BINDING AGENTS DIRECTED TO α5β1 AND USES THEREOF |
| WO2011060206A2 (en) | 2009-11-13 | 2011-05-19 | U3 Pharma Gmbh | Material and methods for treating or preventing her-3 associated diseases |
| EP2896632A2 (en) | 2009-11-13 | 2015-07-22 | U3 Pharma GmbH | Material and methods for treating or preventing HER-3 associated diseases |
| US9101760B2 (en) | 2009-11-13 | 2015-08-11 | U3 Pharma Gmbh | Material and methods for treating or preventing HER-3 associated diseases |
| US9803025B2 (en) | 2009-11-13 | 2017-10-31 | Amgen, Inc. | Material and methods for treating or preventing HER-3 associated diseases |
| WO2012018404A2 (en) | 2010-08-06 | 2012-02-09 | U3 Pharma Gmbh | Use of her3 binding agents in prostate treatment |
| WO2012154999A1 (en) | 2011-05-10 | 2012-11-15 | Amgen Inc. | Methods of treating or preventing cholesterol related disorders |
| WO2013075048A1 (en) | 2011-11-16 | 2013-05-23 | Amgen Inc. | Methods of treating epidermal growth factor deletion mutant viii related disorders |
| WO2016016859A1 (en) | 2014-07-31 | 2016-02-04 | Amgen Research (Munich) Gmbh | Optimized cross-species specific bispecific single chain antibody constructs |
| WO2016166360A1 (en) | 2015-04-17 | 2016-10-20 | Bayer Pharma Aktiengesellschaft | Bispecific antibody constructs for cdh3 and cd3 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62170639A (ja) | 1987-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0368180B2 (ko) | ||
| GB2058873A (en) | System for constructing a building | |
| JP3721448B2 (ja) | 防蟻用断熱板の施工方法 | |
| JP3758173B2 (ja) | 建築物用鉄骨基礎材と該鉄骨基礎材を用いた建築物用コンクリート基礎の形成方法。 | |
| JP5051359B2 (ja) | 下地鋼材の固定構造 | |
| JP2004225461A (ja) | 基礎上の空隙構造 | |
| JP2965195B2 (ja) | 住宅用基礎構造 | |
| JP4551553B2 (ja) | 換気孔付き台輪、換気孔無し台輪、基礎と換気孔付き台輪の接合構造および基礎と換気孔無し台輪の接合構造 | |
| JP3717310B2 (ja) | コンクリート部材の接合構造 | |
| JP4242803B2 (ja) | 張上下地兼堰板支持用のコンクリート面への埋込部材と、その部材を用いたコンクリート型枠形成工法 | |
| JPS5814744Y2 (ja) | 竪樋固定具 | |
| JPS5847124Y2 (ja) | 可搬建築物の固定構造 | |
| JPS6337364Y2 (ko) | ||
| JP3491706B2 (ja) | ルーフプレート | |
| JP2577385Y2 (ja) | 壁パネルの設置構造 | |
| SU996658A1 (ru) | Стыковое соединение сборных железобетонных элементов | |
| JPH0142599Y2 (ko) | ||
| JP3248974B2 (ja) | 屋根パネルの取付構造とその取付方法 | |
| JPS603223Y2 (ja) | 壁下部の構造 | |
| JPS6043548A (ja) | 構造物の構築方法及び構築部材 | |
| JPH0431376Y2 (ko) | ||
| KR950001687Y1 (ko) | 울타리용 지주의 고정구조 | |
| JPH0417718Y2 (ko) | ||
| JP2602685Y2 (ja) | 狭小地における外壁材の固定構造 | |
| JP2008121239A (ja) | 基礎の補強構造 |